Clinical Trial Update: GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

View source ↗

Summary

A completed clinical trial evaluating the combination of GLP-1 receptor agonists and SGLT2 inhibitors for reducing major adverse cardiovascular events in adults…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonists
• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Diabetes Mellitus, Type 2, Myocardial Infarction | Status: COMPLETED